Lisanti Capital Growth’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Lisanti Capital Growth’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-72,160	Closed	-$9.84M	–	157
2020 Q3	$9.84M	Buy	+72,160	New	+$7.67M	1.82%	8
2020 Q2	–	Sell	-23,220	Closed	-$1.09M	–	156
2020 Q1	$1.09M	Buy	+23,220	New	+$1.49M	0.36%	83

Lisanti Capital Growth's MYOK Position: Q4 2020 in Review

Lisanti Capital Growth sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 72,160 shares — an estimated $9.84M sold.

Lisanti Capital Growth first reported a position in MYOK in Q1 2020 and held it in 2 quarters. The position peaked at $9.84M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Lisanti Capital Growth reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Lisanti Capital Growth sold 72,160 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $9.84M.
Lisanti Capital Growth first reported a position in MyoKardia, Inc. Common Stock in Q1 2020 and held it in 2 quarters.
Lisanti Capital Growth's MyoKardia, Inc. Common Stock position peaked at $9.84M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Lisanti Capital Growth's 13F filing for Q4 2020, filed 10 Feb 2021.